Class II recall: Lexia LLC: Broadway Joe's Pain Cream, (Histamine Dihydrochloride 0.025%), 1500mg CBD Isolat
FDA reports a Class II recall of Broadway Joe's Pain Cream, a topical product containing Histamine Dihydrochloride 0.025%, 1500mg CBD Isolate, and 1000mg Hempseed oil, produced for Broadway Joe's of Franklin, TN. The recall, identified by NDC 83088-8120-5, was initiated due to CGMP deviations involving potential contamination of raw material used in the product.
Most relevant for: Patients who have used or purchased Broadway Joe's Pain Cream topical product.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More allergy & immunology updates
- Allergic-like reactions to mRNA vaccines occurred only in high-risk groupOct 13, 2026
- Oral deucrictibant speeds symptom relief in HAE attacks, trial findsOct 8, 2026
- PGE2 signaling found to modulate MRGPRX2-mediated anaphylaxis severitySep 30, 2026
- Registry data compare rapamycin and leniolisib in APDSSep 28, 2026
- Mepolizumab linked to sustained airway remodeling benefits at 3 yearsSep 28, 2026